Publications
Immuno-Oncology Brings New Opportunities for Developers of Targeted Cytotoxics
The time is right to partner with immunotherapy firms, and for immunotherapy firms similarly to collaborate with those makers of targeted agents.
September, 2015
Immunotherapy: Big Pharmas Seductive Embrace
December, 2014
Launch or License: Taking Your First Drug To Europe
December, 2013